| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5497952 | Applied Radiation and Isotopes | 2017 | 7 Pages |
Abstract
Mass-separated francium beams (211Fr or 213Fr) were implanted into solid targets for producing 211Rn (14.6Â h half-life) or 209At (5.41Â h), in situ. 211Rn was transferred to dodecane and isolated from contaminants, providing sources for 211At (7.21Â h) production by 211Rn decay (73%). 209At was recovered with high radionuclidic purity in aqueous solutions, directly. These experiments demonstrated Fr beam implantations as a novel method for producing preclinical quantities of 211Rn/211At (for therapy) and 209At (for imaging).
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jason R Crawford, Peter Kunz, Hua Yang, Paul Schaffer, Thomas J Ruth,